The borderline diagnosis II: Biology, genetics, and clinical course

Biological Psychiatry

Volumn 51, Issue 12, 2002, Pages 951-963

  Skodol, Andrew E ^a,b   Siever, Larry J ^c,d   Livesley, W John ^e   Gunderson, John G ^f   Pfohl, Bruce ^g   Widiger, Thomas A ^h  

^a College of Physicians and Surgeons ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f MCLEAN HOSPITAL   (United States)

^g UNIVERSITY OF IOWA   (United States)

^h UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Affective instability; Borderline; Course; Genetics; Impulsive aggression; Personality disorder

Indexed keywords

AGGRESSIVENESS; ANXIETY; BORDERLINE STATE; CHOLINERGIC SYSTEM; CLINICAL FEATURE; COGNITION; COMORBIDITY; CORRELATION ANALYSIS; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENETIC TRAIT; HEREDITY; HUMAN; NEUROSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEROTONINERGIC SYSTEM; SEXUAL ABUSE; SUBSTANCE ABUSE;

AFFECT; BORDERLINE PERSONALITY DISORDER; HUMANS; IMPULSIVE BEHAVIOR; TEMPERAMENT;

EID: 0037097410     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01325-2     Document Type: Review

References (120)

1. Subaffective disorders: Dysthymic, cyclothymic, and bipolar II disorders in the "borderline" realm
2. The relationship between DSM-III symptom disorders (Axis I) and personality disorders (Axis II) in an outpatient population
3. Organic brain dysfunction and the borderline syndrome
4. 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor?
5. The stability and distinctness of borderline personality disorder
6. Familial transmission of schizotypal and borderline personality disorders
7. Impulsiveness
8. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking
9. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies
10. Blood platelet uptake of serotonin in episodic aggression
11. Aggression, suicide, and serotonin: Relationships to CSF amine metabolites
12. An inventory for assessing different kinds of hostility
13. Studies in violent and nonviolent male parolees: II. Laboratory and psychometric measurements of impulsivity
14. Studies of violent and nonviolent male parolees: I. Laboratory and psychometric measurements of aggression
15. Convergence of two systems for assessing personality disorder
16. A unified biosocial theory of personality and its role in the development of anxiety states: A reply to commentaries
17. The Tridimensional Personality Questionnaire: US normative data
18. Neurotransmitter function in personality disorders
19. Intermittent explosive disorder
20. Heritability of irritable impulsiveness: A study of twins reared together and apart
21. Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men
22. Serotonin function and antiaggressive response to fluoxetine: A pilot study
23. Growth hormone responses to intravenous clonidine challenge correlate with behavioral irritability in psychiatric patients and healthy volunteers
24. Serotonergic studies in patients with affective and personality disorders: Correlates with suicidal and impulsive aggressive behavior
25. Fluoxetine trial in borderline personality disorder
26. Personality disorders in the families of depressed, schizophrenic, and never-ill probands
27. Personality disorders and the five-factor model of personality
28. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking
29. The definition of personality disorders and the criteria appropriate for their description
30. D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects
31. Positron-emission tomography and personality disorders
32. Stability and course of personality disorders
33. Course and stability of personality disorders
34. Stability and course of personality disorders: The need to consider comorbidities and continuities between Axis I psychiatric disorders and Axis II personality disorders
35. Borderline and schizophrenic patients: A comparative study
36. The Affective Lability Scale: Development, reliability, and validity
37. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse
38. Childhood trauma in borderline personality disorder
39. Heritability of personality disorder traits: A twin study
40. Intravenous procaine as a probe of limbic system activity in psychiatric patients and normal controls
41. Anterior paralimbic mediation of procaine-induced emotional and psychosensory experiences
42. The concept of personality organization: A long-term comparative follow-up study with special reference to borderline personality organization
43. A multitrait-multimethod examination of affect structure: Hedonic level and emotional intensity
44. Behavioral disinhibition induced by tryptophan depletion in nonalcoholic young men with multigenerational family histories of paternal alcoholism
45. Stability and change in personality disorder features: The Longitudinal Study of Personality Disorders
46. Association of anxiety -related traits with a polymorphism in the serotonin transporter gene regulatory region
47. Prospective follow-up study of borderline personality disorder: Prognosis, prediction of outcome, and axis II comorbidity
48. Stability of borderline personality disorder
49. The occurrence of borderline personality disorder in the families of borderline patients
50. Low cerebrospinal fluid 5- hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior
51. Trait and behavioral prototypes of personality disorder
52. Systematic approach to the delineation of personality disorders
53. A study of the factorial structure of personality pathology
54. Factorial structure of traits delineating personality disorders in clinical and general population samples
55. Genetic and environmental contributions to dimensions of personality disorder
56. Phenotypic and genetic structure of traits delineating personality disorder
57. The genetic basis of personality structure
58. Trait-state artifacts and the diagnosis of personality disorders
59. Familial transmission of DSM-III borderline personality disorder
60. Prevalences of personality disorders (DSM-III-R) in the community
61. The dopamine D(4) receptor gene and novelty seeking
62. Fluoxetine in the treatment of borderline and schizotypal personality disorders
63. The stability of personality disorder diagnosis
64. The borderline syndrome. I. Testing three diagnostic systems
65. Prediction of outcome in BPD
66. The longitudinal profile of BPD: Contributions from The Chestnut Lodge Follow-Up Study
67. The genetics of personality disorder
68. The persistence of borderline personality disorder in adolescence
69. Suicide, impulsive aggression and HTR1B genotype
70. Tryptophan hydroxylase genotype is associated with impulsive-aggression measures: A preliminary study
71. Blunted prefrontal cortical FDG-PET response to meta-chlorophenylpiperazine in impulsive aggression
72. Serotonin and the prediction of response time to fluoxetine in patients with mild depression
73. Genetics of personality disorders: Perspectives from personality and psychopathology research
74. Comorbidity of Axis I and Axis II disorders
75. The treatment of borderline personality disorder in light of the research on its long-term outcome
76. Follow-up studies of BPD: A critical review
77. Long-term follow-up of borderline patients in a general hospital
78. Longitudinal studies of personality disorders
79. Behavioral genetics and personality
80. The validity of the DSM-III borderline personality disorder: A phenomenologic, family history, treatment, and long-term follow-up study
81. Brain abnormalities in murderers indicated by positron emission tomography
82. Selective reductions in prefrontal glucose metabolism in murderers
83. Familiality of DSM-III dramatic and anxious personality clusters
84. Factor analysis of DSM-III-R borderline personality disorder criteria in psychiatric inpatients
85. A family history study of borderline subtypes
86. The amphetamine challenge test in patients with borderline disorder
87. Amphetamine response in borderline patients
88. Plasma homovanillic acid in schizotypal personality disorder patients and controls
89. Dl-Fenfluramine response in impulsive personality disorder assessed with 18F-deoxyglucose positron emission tomography
90. New biological research strategies for personality disorders
91. The serotonin system and aggressive personality disorder
92. Borderline personality disorders and the anxiety disorders
93. Borderline inpatients with affective disorder: Preliminary follow-up data
94. Co-occurrence of mood and personality disorders: A report from the Collaborative Longitudinal Personality Disorders Study (CLPS)
95. Psychiatric disorders in the families of borderline patients
96. Depressive response to physostigmine challenge in borderline personality disorder patients
97. The cholinergic and noradrenergic neurotransmitter systems and affective instability in borderline personality disorder
98. An outcome study of psychotherapy for patients with borderline personality disorders
99. The course of borderline personality disorder
100. Long-term outcome in personality disorders
101. Psychiatrically ill relatives of borderline patients: A family study
102. Genetic and nosological aspects of schizotypal and borderline personality disorders: A twin study
103. Sampling problems in twin research
104. A twin study of personality disorders
105. Structures of personality and their relevance to psychopathology
106. The DSM-III-R categorical personality disorder diagnoses: A critique and an alternative
107. Toward an empirical classification for the DSM-IV
108. A description of the DSM-III-R and DSM-IV personality disorders with the five-factor model of personality
109. Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder
110. Outcome studies of borderline personality disorder
111. DSM-III disorders in the families of borderline outpatients
112. The psychophysiology of sensation seeking
113. A correlational test in humans of the biological models of sensation seeking, impulsivity, and anxiety
114. Development of a Sensation-Seeking Scale